|
|
Volumn 19, Issue 2, 1997, Pages 244-245
|
|
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
CHLORPROMAZINE;
CLOMIPRAMINE;
CLOZAPINE;
CYTOCHROME P450 ISOENZYME;
DOXEPIN;
FLUOXETINE;
FLUPHENAZINE;
FLUVOXAMINE;
HALOPERIDOL;
LOXAPINE;
MESORIDAZINE;
NIFEDIPINE;
OMEPRAZOLE;
PAROXETINE;
PERPHENAZINE;
PROPRANOLOL;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TERFENADINE;
THIORIDAZINE;
TIOTIXENE;
TRIFLUOPERAZINE;
VERAPAMIL;
COMBINATION CHEMOTHERAPY;
DEPRESSION;
DRUG MONITORING;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
1-NAPHTHYLAMINE;
ANTIDEPRESSIVE AGENTS;
DRUG INTERACTIONS;
FLUOXETINE;
HUMANS;
PAROXETINE;
SERTRALINE;
|
|
EID: 0031441325
PISSN: 01634356
EISSN: None
Source Type: Journal
DOI: 10.1097/00007691-199704000-00024 Document Type: Letter |
|
Times cited : (12)
|
|
References (3)
|
